Ozempic (farmaci GPL-1) vs. modulazione acustica. A te la scelta. ~~ La modulazione acustica delle cellule adipose, come descritto nello studio dell'Università di Kyoto del 2025, e Ozempic (semaglutide), un agonista del recettore del GLP-1, mirano entrambe ad affrontare l'obesità, ma differiscono in modo significativo nel meccanismo, nell'applicazione e nello stadio di sviluppo. L'approccio delle onde sonore sopprime in modo non invasivo la differenziazione degli adipociti fino al 15% in vitro attraverso la meccanotrasduzione e le vie mediate da Ptgs2, offrendo una potenziale terapia priva di farmaci e minima con effetti collaterali, sebbene rimanga in fase di ricerca iniziale con un'efficacia in vivo non dimostrata. Al contrario, Ozempic, un farmaco iniettabile approvato dalla FDA, promuove la perdita di peso imitando il GLP-1, riducendo l'appetito e rallentando lo svuotamento gastrico, ottenendo una riduzione del peso corporeo del 15-20% negli studi clinici. Tuttavia, comporta rischi come nausea, pancreatite e dipendenza a lungo termine. Sebbene Ozempic sia un trattamento sistemico collaudato, la terapia acustica non è invasiva e corrisponde all'impatto di Ozempic.
Sonic BOOM!! Soundwaves help you lose weight with no injections no drugs! ~~ A groundbreaking study published in Communications Biology on April 19, 2025, by researchers at Kyoto University, led by Masahiro Kumeta, has revealed that audible sound waves can influence cellular behavior, specifically suppressing fat cell (adipocyte) differentiation by modulating gene expression. Titled “Acoustic modulation of mechanosensitive genes and adipocyte differentiation,” the study demonstrates how sound, as a non-invasive mechanical stimulus, can alter cellular processes, opening potential avenues for applications in biotechnology and obesity management. Background and Motivation Cells are known to respond to mechanical stimuli through mechanotransduction, a process where physical forces are converted into biochemical signals. While previous research has explored high-intensity ultrasound or low-vibration stimuli, the effects of audible sound waves (20 Hz to 20 kHz, within the human hearing range) on cellular behavior have been underexplored due to challenges in isolating sound’s effects from confounding factors like heat or vibrations. Kumeta’s team built on their 2018 findings, which showed audible sound could modulate mechanosensitive genes, but sought to refine the experimental setup to directly attribute changes to acoustic waves and investigate their impact on fat cell development. The researchers designed a precise sound emission system to deliver controlled acoustic waves to cultured cells, minimizing extraneous effects. The setup involved: •Vibration Transducer: A digital audio player connected to an amplifier sent sound signals to an upside-down vibration transducer mounted on a shelf. This transducer transmitted acoustic waves through a diaphragm to a cell culture dish, simulating physiological sound levels (approximately 100 Pa, comparable to loud conversational or musical sound). •Sound Patterns: Three sound types were tested: a 440 Hz sine wave (equivalent to the musical note A), a 14 kHz high-frequency tone, and white noise (random broadband sound). These were applied continuously for 2 or 24 hours or in specific schedules for differentiation experiments. •Cell Types: The study primarily used murine C2C12 myoblasts (muscle precursor cells) for gene expression analysis and 3T3-L1 preadipocytes (fat cell precursors) for adipocyte differentiation studies. •Analysis Techniques: RNA sequencing identified differentially expressed genes, while microscopy and biochemical assays assessed cellular morphology, differentiation, and molecular pathways. Specific focus was placed on the gene Ptgs2 (prostaglandin-endoperoxide synthase 2, also known as Cox-2) due to its robust response to sound. The experiments were conducted with controls to ensure sound-specific effects, such as maintaining consistent temperature and minimizing vibrational artifacts. For adipocyte differentiation, 3T3-L1 cells were exposed to sound during the initial three-day induction phase with a differentiation medium containing methylisobutylxanthine, dexamethasone, and insulin (MDI), followed by four days in insulin-only medium. The findings have profound implications for both fundamental biology and clinical applications: •Non-Invasive Therapies: Since sound is non-material, acoustic stimulation offers a safe, immediate, and non-invasive method to modulate cellular behavior. The study suggests potential for sound-based therapies to manage obesity by inhibiting fat cell formation without drugs or surgery. •Medical Applications: Beyond obesity, acoustic modulation could guide stem cell differentiation, promote tissue healing, or regulate inflammation, given Ptgs2’s role in these processes. The non-invasive nature of sound makes it appealing for clinical settings, potentially delivered via wearable devices. Link:
Mostra originale
64.689
165
Il contenuto di questa pagina è fornito da terze parti. Salvo diversa indicazione, OKX non è l'autore degli articoli citati e non rivendica alcun copyright sui materiali. Il contenuto è fornito solo a scopo informativo e non rappresenta le opinioni di OKX. Non intende essere un'approvazione di alcun tipo e non deve essere considerato un consiglio di investimento o una sollecitazione all'acquisto o alla vendita di asset digitali. Nella misura in cui l'IA generativa viene utilizzata per fornire riepiloghi o altre informazioni, tale contenuto generato dall'IA potrebbe essere impreciso o incoerente. Leggi l'articolo collegato per ulteriori dettagli e informazioni. OKX non è responsabile per i contenuti ospitati su siti di terze parti. Gli holding di asset digitali, tra cui stablecoin e NFT, comportano un elevato grado di rischio e possono fluttuare notevolmente. Dovresti valutare attentamente se effettuare il trading o detenere asset digitali è adatto a te alla luce della tua situazione finanziaria.